ATE463509T1 - Stabilisierung von herz-troponin - Google Patents

Stabilisierung von herz-troponin

Info

Publication number
ATE463509T1
ATE463509T1 AT06750874T AT06750874T ATE463509T1 AT E463509 T1 ATE463509 T1 AT E463509T1 AT 06750874 T AT06750874 T AT 06750874T AT 06750874 T AT06750874 T AT 06750874T AT E463509 T1 ATE463509 T1 AT E463509T1
Authority
AT
Austria
Prior art keywords
troponin
proteins
complex
stabilized
stabilization
Prior art date
Application number
AT06750874T
Other languages
English (en)
Inventor
Don Laird
Charles Young
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE463509T1 publication Critical patent/ATE463509T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06750874T 2005-04-28 2006-04-20 Stabilisierung von herz-troponin ATE463509T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67554205P 2005-04-28 2005-04-28
PCT/US2006/014958 WO2006116005A2 (en) 2005-04-28 2006-04-20 Stabilization of cardiac troponin

Publications (1)

Publication Number Publication Date
ATE463509T1 true ATE463509T1 (de) 2010-04-15

Family

ID=37027832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06750874T ATE463509T1 (de) 2005-04-28 2006-04-20 Stabilisierung von herz-troponin

Country Status (8)

Country Link
US (1) US20070082410A1 (de)
EP (1) EP1877432B1 (de)
JP (1) JP2008539434A (de)
AT (1) ATE463509T1 (de)
CA (1) CA2606333A1 (de)
DE (1) DE602006013443D1 (de)
ES (1) ES2342104T3 (de)
WO (1) WO2006116005A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201812300A (zh) * 2016-09-13 2018-04-01 日商富士麗比歐股份有限公司 心肌肌鈣蛋白之測定方法及測定試藥
WO2022009973A1 (ja) * 2020-07-10 2022-01-13 積水メディカル株式会社 Ｔａｒｃを含有する組成物、及びｔａｒｃの保存安定性向上方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130280C (en) * 1993-08-24 1999-08-31 Lilian Lee Method for purification of cardiac troponin i
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
FR2734267B1 (fr) * 1995-05-16 1997-08-01 Pasteur Sanofi Diagnostics Composition stabilisee de troponine pour immunoessais et procede de preparation d'une telle composition stabilisee
DE19524572A1 (de) * 1995-07-06 1997-01-09 Bayer Ag Verfahren zur Herstellung eines synthetischen Kalibrators für den Einsatz in Immunoassays, bestehend aus den Analyten oder Teilsequenzen davon, die an inerten Trägermoleküle konjugiert sind
US5834210A (en) * 1997-05-23 1998-11-10 Spectral Diagnostics, Inc. Stable troponin subunits and complexes
WO1998056900A1 (en) * 1997-06-13 1998-12-17 Medical Analysis Systems Inc. (Mas) Stabilized compositions of cardiac markers
KR100508695B1 (ko) * 2001-02-13 2005-08-17 한국과학기술연구원 인슐린의 경구투여용 제형과 그의 제조방법
US6538104B2 (en) * 2001-04-27 2003-03-25 Medical Analysis Systems, Inc. Stabilization of cardiac troponin I subunits and complexes
US20040022792A1 (en) * 2002-06-17 2004-02-05 Ralph Klinke Method of stabilizing proteins at low pH
US20050136542A1 (en) * 2003-12-19 2005-06-23 Beckman Coulter, Inc. Stabilized liquid reference solutions

Also Published As

Publication number Publication date
WO2006116005A3 (en) 2007-02-15
CA2606333A1 (en) 2006-11-02
ES2342104T3 (es) 2010-07-01
DE602006013443D1 (de) 2010-05-20
WO2006116005A2 (en) 2006-11-02
EP1877432A2 (de) 2008-01-16
EP1877432B1 (de) 2010-04-07
US20070082410A1 (en) 2007-04-12
JP2008539434A (ja) 2008-11-13

Similar Documents

Publication Publication Date Title
Ryan et al. Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology
Jonsson et al. Semenogelins I and II bind zinc and regulate the activity of prostate-specific antigen
HENSCHEN‐EDMAN Fibrinogen non‐inherited heterogeneity and its relationship to function in health and disease
ATE486281T1 (de) Patientenklassifizierung
Moreno-Arotzena et al. Inducing chemotactic and haptotactic cues in microfluidic devices for three-dimensional in vitro assays
CY1112797T1 (el) Συμπλοκο σκληροστινης και νογκινης ή χορδινης, και παραγοντες που ρυθμιζουν το σχηματισμο του εν λογω συμπλοκου
DE60322339D1 (de) Bindungsproteine als biosensoren
NO20076475L (no) Enkeltdomene VHH antilegemer mot Van Willebrand faktor
NO20080629L (no) Tiazolderivater som AMPK-aktiverere
ATE525648T1 (de) Testelement mit nanofasern
HUP0100302A2 (hu) Eljárások a szerin/treonin protein-kináz funkció módositására 5-azakinoxalin-vázas vegyületekkel
DE60024669D1 (de) Hämatologische bestimmung und reagenz
NO20052992L (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
ATE310531T1 (de) Stabilisierte pharmazeutische zusammensetzungen von hedgehog-proteinen und deren verwendung
TR200003159T2 (tr) Antipicornaviral bileşikler, hazırlanışları ve kullanımları
Cui et al. Crude and purified proteasome activity assays are affected by type of microplate
DK0458937T3 (da) Varianter af PAI-2
DE60331422D1 (de) Fluoreszierendes protein aus aequorea coerulescens und ihre verwendungen
ATE463509T1 (de) Stabilisierung von herz-troponin
Dayananda et al. Escherichia coli-derived von Willebrand factor-A2 domain fluorescence/Förster resonance energy transfer proteins that quantify ADAMTS13 activity
DE60140707D1 (de) GSK3-Polypeptide
Taylor et al. Induced fit activation mechanism of the exceptionally specific serine protease, complement factor D
CN101171514B (zh) 肺表面活性蛋白的稳定化方法
NO20053990L (no) Assay for proteinisoformer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties